December 13, 2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.

More news

02-15-2018 ICMAB traps sunlight with superabsorbent nanomaterials 02-08-2018 ERC Grants & the Catalan Research System: a Success Story 02-01-2018 The best of the Bioregion of Catalonia in 2017 01-25-2018 Barcelona, a business friendly capital 01-18-2018 When Ideas Generated at the UAB make cows happy 01-11-2018 2017, the Year When Stradivarius settled Down In the Barcelona Synchrotron Park
1 2 3 4 5 6